These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9533068)

  • 21. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 22. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
    MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
    Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 25. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 26. [Severe heart failure. Carvedilol lowers mortality].
    MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
    [No Abstract]   [Full Text] [Related]  

  • 27. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.
    Fraga R; Franco FG; Roveda F; de Matos LN; Braga AM; Rondon MU; Rotta DR; Brum PC; Barretto AC; Middlekauff HR; Negrão CE
    Eur J Heart Fail; 2007; 9(6-7):630-6. PubMed ID: 17475552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carvedilol (dilatrend) treatment in cardiac failure].
    Drapkina OM; klimenkov AV; Ivashkin VT
    Ter Arkh; 2004; 76(12):88-90. PubMed ID: 15724937
    [No Abstract]   [Full Text] [Related]  

  • 29. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol for anthracycline cardiomyopathy prevention.
    Florenzano F; Salman P
    J Am Coll Cardiol; 2007 May; 49(21):2142; author reply 2142-3. PubMed ID: 17531665
    [No Abstract]   [Full Text] [Related]  

  • 31. Carvedilol.
    Frishman WH
    Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
    [No Abstract]   [Full Text] [Related]  

  • 32. Now there are four: Carvedilol takes its place in therapeutical line-up for heart failure.
    Phillips L
    Hosp Technol Ser; 1997 Mar; 16(3):6-7. PubMed ID: 10166705
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol offers women with heart problems the same clinical benefits as men.
    Cardiovasc J S Afr; 2002; 13(2):84. PubMed ID: 12166361
    [No Abstract]   [Full Text] [Related]  

  • 35. Special considerations for carvedilol use in heart failure.
    Yancy CW
    Am J Cardiol; 2004 May; 93(9A):64B-8B. PubMed ID: 15144941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid carvedilol up-titration in hospitalized patients with systolic heart failure.
    Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
    J Heart Lung Transplant; 2008 Aug; 27(8):914-6. PubMed ID: 18656807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree?
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.